domingo, 30 de octubre de 2016

Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy. - PubMed - NCBI

Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy. - PubMed - NCBI



 2016 Oct 24. doi: 10.1001/jama.2016.16437. [Epub ahead of print]

Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy.


PMID:
 
27775756
 
DOI:
 
10.1001/jama.2016.16437

[PubMed - as supplied by publisher]